BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8437240)

  • 21. Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis.
    Zhou D; Shen Y; Chalifoux L; Lee-Parritz D; Simon M; Sehgal PK; Zheng L; Halloran M; Chen ZW
    J Immunol; 1999 Feb; 162(4):2204-16. PubMed ID: 9973496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW; Shen L; Miller MD; Ghim SH; Hughes AL; Letvin NL
    J Immunol; 1992 Dec; 149(12):4060-6. PubMed ID: 1460291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
    Johnson RP; Glickman RL; Yang JQ; Kaur A; Dion JT; Mulligan MJ; Desrosiers RC
    J Virol; 1997 Oct; 71(10):7711-8. PubMed ID: 9311855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope.
    Sharpe SA; Cope A; Dowall S; Berry N; Ham C; Heeney JL; Hopkins D; Easterbrook L; Dennis M; Almond N; Cranage M
    J Gen Virol; 2004 Sep; 85(Pt 9):2591-2602. PubMed ID: 15302953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Huete JM; Chatis PA; Schmitz JE; Kuroda MJ; Letvin NL; Reimann KA
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):349-60. PubMed ID: 11242521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system.
    Evans DT; Chen LM; Gillis J; Lin KC; Harty B; Mazzara GP; Donis RO; Mansfield KG; Lifson JD; Desrosiers RC; Galán JE; Johnson RP
    J Virol; 2003 Feb; 77(4):2400-9. PubMed ID: 12551977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
    Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
    J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.
    Yasutomi Y; Robinson HL; Lu S; Mustafa F; Lekutis C; Arthos J; Mullins JI; Voss G; Manson K; Wyand M; Letvin NL
    J Virol; 1996 Jan; 70(1):678-81. PubMed ID: 8523593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys.
    Kuroda MJ; Schmitz JE; Charini WA; Nickerson CE; Lifton MA; Lord CI; Forman MA; Letvin NL
    J Immunol; 1999 May; 162(9):5127-33. PubMed ID: 10227983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.
    Letvin NL; Schmitz JE; Jordan HL; Seth A; Hirsch VM; Reimann KA; Kuroda MJ
    Immunol Rev; 1999 Aug; 170():127-34. PubMed ID: 10566147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.
    Yasutomi Y; Palker TJ; Gardner MB; Haynes BF; Letvin NL
    J Immunol; 1993 Nov; 151(9):5096-105. PubMed ID: 7691965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epitope in the V1 domain of the simian immunodeficiency virus (SIV) gp120 protein is recognized by CD8+ cytotoxic T lymphocytes from an SIV-infected rhesus macaque.
    Erickson AL; Walker CM
    J Virol; 1994 Apr; 68(4):2756-9. PubMed ID: 7511178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preservation of functional virus-specific memory CD8+ T lymphocytes in vaccinated, simian human immunodeficiency virus-infected rhesus monkeys.
    Acierno PM; Schmitz JE; Gorgone DA; Sun Y; Santra S; Seaman MS; Newberg MH; Mascola JR; Nabel GJ; Panicali D; Letvin NL
    J Immunol; 2006 May; 176(9):5338-45. PubMed ID: 16622001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus.
    Sharpe SA; Whatmore AM; Hall GA; Cranage MP
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1923-7. PubMed ID: 9266989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine protection against functional CTL abnormalities in simian human immunodeficiency virus-infected rhesus monkeys.
    McKay PF; Schmitz JE; Barouch DH; Kuroda MJ; Lifton MA; Nickerson CE; Gorgone DA; Letvin NL
    J Immunol; 2002 Jan; 168(1):332-7. PubMed ID: 11751978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys.
    Schmitz JE; Lifton MA; Reimann KA; Montefiori DC; Shen L; Racz P; Tenner-Racz K; Ollert MW; Forman MA; Gelman RS; Vogel CW; Letvin NL
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):195-202. PubMed ID: 10029251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection.
    Petry H; Dittmer U; Stahl-Hennig C; Coulibaly C; Makoschey B; Fuchs D; Wachter H; Tolle T; Morys-Wortmann C; Kaup FJ
    J Virol; 1995 Mar; 69(3):1564-74. PubMed ID: 7853490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar abnormalities of idiotype and immunoglobulin light chain expression and of cell-mediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
    Grant MD; Whaley MD; Mayne A; Hoffmann GW; Ansari AA
    Immunol Cell Biol; 1996 Feb; 74(1):38-44. PubMed ID: 8934652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.